Nerve stimulation for cluster headaches

March 25, 2010

Occipital nerve stimulation has been under investigation for the treatment of difficult to treat migraine headaches for the past several years with promising results.  A recent study at the Mayo Clinic in Scottsdale, AZ suggests that this treatment may also help relieve chronic cluster headaches.  It is less surprising that the occipital nerve stimulation works for cluster headaches than for migraines.  It is not unusual for cluster headache patients to complain of pain not only in the eye, but also in the back of the head on the same side.  Also, occipital nerve block with steroids has been shown to abort an episode of episodic cluster headaches and is widely used by headache specialists.  In chronic cluster patients this block may provide temporary relief and these patients may be good candidates for an occipital nerve stimulation.  The stimulator is usually implanted by a neurosurgeon in an out-patient procedure.  The wire electrode and the battery are embedded under the skin.  Another miniature stimulator which has been in development contains both the electrode and the battery in a very small capsule-size device.  This miniature stimulator is much easier to implant and it is less bothersome.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe